2022

1. Analysis of therapy monitoring in the International Congenital Adrenal Hyperplasia Registry

   Clinical Endocrinology, Vol. 97, Núm. 5, pp. 551-561

2. Intralymphatic GAD-Alum (Diamyd®) Improves Glycemic Control in Type 1 Diabetes With HLA DR3-DQ2

   Journal of Clinical Endocrinology and Metabolism, Vol. 107, Núm. 9, pp. 2644-2651